NextBio is privately owned software company that provides a platform for life science researchers to search, discover, and share knowledge across public and proprietary data.
Nextbio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004 and based in Cupertino California, USA.
The NextBio Platform is an ontology-based semantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease and compound ontologies. This framework contains information from diverse organisms, platforms, data types and research areas is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data.
The enterprise version of the NextBio platform is being used in life science R&D and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and [[Regeneron Pharmaceuticals. This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly-available data. Scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research.
NextBio was a receiver of the Frost & Sullivan North American Life Sciences Customer Value Enhancement Award in 2008. Since the release it has had more than 1,500,000 visitors.
Percent of global internet users visiting nextbio.com
1 month avg.
3 month avg.
3 month change
0.0017%
0.0015%
66%
Compete.com
April 2009
Ranking out of the top one million most visited sites on the Internet: 37,672 – Unique Visitors (US): 52,719
Top Countries
Country
% User
% Pageviews
Rank in country
USA
29.7%
34.4%
51946
India
20.7%
20.0%
30559
Iran
5.7%
6.6%
15111
Germany
4.0%
4.8%
128198
Italy
2.9%
3.6%
57997
more...
Indonesia
2.9%
2.7%
48454
United Kingdom
2.9%
2.3%
105718
China
2.4%
1.7%
173239
Netherlands
2.4%
2.5%
39842
Egypt
2.4%
1.8%
20856
Canada
2.3%
2.0%
66057
Spain
1.8%
2.5%
57410
Australia
1.0%
0.8%
113629
Greece
0.9%
0.7%
52814
Mexico
0.9%
0.7%
86809
Thailand
0.8%
0.7%
57855
France
0.7%
0.6%
160156
Brazil
0.6%
0.5%
142863
Other
15.0%
11.0%
less...
Top Subdomains
Subdomains
% Pageviews
Pageviews per user
nextbio.com
100.0%
1.8
less...
Page Views
Number of unique pages viewed per user per day
1 month avg.
3 month avg.
3 month change
1.69
1.66
6%
Quantcast.com
Popularity
41 bookmarks at Delicious
2  results in Reddit  
34 inbound links from Wikipedia
Online
Ads by Google
Ads by Google
Technical Data
Registrant
NextBio 6 Results Way Cupertino, CA 95014 US
Domain name: NEXTBIO.COM
Administrative Contact
Akhtari, Saeid akhtari(at)gmail.com 6 Results Way Cupertino, CA 95014 US 408 307 5237 Fax: 408 777 8091
Technical Contact:
Akhtari, Saeid akhtari(at)gmail.com 6 Results Way Cupertino, CA 95014 US 408 307 5237 Fax: 408 777 8091
Registration Service Provider: Web.com, droneteam(at)interland.com 1-404-260-2477 1-404-260-8685 (fax) http://www.web.com This company may be contacted for domain login/passwords, DNS/Nameserver changes, and general domain support questions.
Registrar of Record: TUCOWS, INC. Record last updated on 21-Sep-2006. Record expires on 18-Feb-2011. Record created on 18-Feb-2004.
Registrar Domain Name Help Center: http://domainhelp.tucows.com
Domain servers in listed order
YNS1.YAHOO.COM YNS2.YAHOO.COM
Domain status: ok
The Data in the Tucows Registrar WHOIS database is provided to you by Tucows for information purposes only, and may be used to assist you in obtaining information about or related to a domain name's registration record.
Tucows makes this information available "as is," and does not guarantee its accuracy.
By submitting a WHOIS query, you agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to: a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass, unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of any Registry Operator or ICANN-Accredited registrar, except as reasonably necessary to register domain names or modify existing registrations.
The compilation, repackaging, dissemination or other use of this Data is expressly prohibited without the prior written consent of Tucows.
Tucows reserves the right to terminate your access to the Tucows WHOIS database in its sole discretion, including without limitation, for excessive querying of the WHOIS database or for failure to otherwise abide by this policy.
Tucows reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by these terms.
NOTE: THE WHOIS DATABASE IS A CONTACT DATABASE ONLY. LACK OF A DOMAIN RECORD DOES NOT SIGNIFY DOMAIN AVAILABILITY.
Company name:nextbio Description:NextBio is a life science search engine that enables researchers and clinicians to access and understand the world s life sciences information. NextBio is open biology ? search across all of the world s life science information, share data, and collaborate. Our goal is for NextBio users to better understand science, make discoveries, and generate hypotheses as never before. Ranking:95,357 Famous in countries:USA, India, Iran, Germany President & CEO:Saeid Akhtari Employee Amount:50
NextBio is privately owned software company that provides a platform for life science researchers to search, discover, and share knowledge across public and proprietary data.
Nextbio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004 and based in Cupertino California, USA.
The NextBio Platform is an ontology-based semantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease and compound ontologies. This framework contains information from diverse organisms, platforms, data types and research areas is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data.
The enterprise version of the NextBio platform is being used in life science R&D and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and [[Regeneron Pharmaceuticals. This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly-available data. Scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research.
NextBio was a receiver of the Frost & Sullivan North American Life Sciences Customer Value Enhancement Award in 2008. Since the release it has had more than 1,500,000 visitors.